AgreementConsulting and Employment Separation Agreement • August 1st, 2024 • REGENXBIO Inc. • Biological products, (no disgnostic substances) • Maryland
Contract Type FiledAugust 1st, 2024 Company Industry JurisdictionThis Consulting and Employment Separation Agreement (the “Agreement”) is entered into as of June 12, 2024, by and between REGENXBIO Inc. (“REGENXBIO”), a Delaware corporation with offices at 9804 Medical Center Drive, Rockville, Maryland 20850, and Ken Mills (“Mr. Mills”), (each a “Party” and collectively the “Parties”).